Jagajothi Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.40 M
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 4.00 M
- Revenue Growth 2.45%
- Profit Growth -44.08%
- Ebitda -331.41%
- Net Worth 13.38%
- Total Assets 46.12%
About Jagajothi Pharma
Jagajothi Pharma Private Limited (JPPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 July 2017 (Seven years and six months 21 days old ). Its registered office is in Virudhunagar, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹4.00 M.
Ramvijayaramesh and Yazhini Ramvijayaramesh serve as directors at the Company.
Company Details
-
Location
Virudhunagar, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33309TN2017PTC117548
-
Company No.
117548
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Jul 2017
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Jagajothi Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramvijayaramesh
|
Director | 13-Jul-2017 | Current |
|
Yazhini Ramvijayaramesh
|
Director | 13-Jul-2017 | Current |
Financial Performance of Jagajothi Pharma.
Jagajothi Pharma Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 2.45% increase. The company also saw a substantial fall in profitability, with a 44.08% decrease in profit. The company's net worth Soared by an impressive increase of 13.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jagajothi Pharma?
Unlock access to Jagajothi Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹4.00 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Sep 2018 | Canara Bank | ₹4.00 M | Open |
How Many Employees Work at Jagajothi Pharma?
Unlock and access historical data on people associated with Jagajothi Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jagajothi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jagajothi Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.